Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 10, 2016, Pages 1847-1860

  Kamphuis, Willem ^a   Kooijman, Lieneke ^a,b   Schetters, Sjoerd ^a   Orre, Marie ^a,c   Hol, Elly M ^a,b,d  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

A ; CD11b; CD11C; Gene expression; Inflammation; Microglia

Indexed keywords

APOLIPOPROTEIN E; CD45 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME; TRANSCRIPTOME;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CARBOHYDRATE METABOLISM; CELL ACTIVATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84979574735     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.07.007     Document Type: Article

References (95)

1. [1] Zotova, E., Holmes, C., Johnston, D., Neal, J.W., Nicoll, J.A., Boche, D., Microglial alterations in human Alzheimer's disease following Abeta42 immunization. Neuropathol. Appl. Neurobiol. 37 (2011), 513–524, 10.1111/j.1365–2990.2010.01156.x.
2. [2] Orre, M., Kamphuis, W., Osborn, L.M., Jansen, A.H., Kooijman, L., Bossers, K., Hol, E.M., Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol. Aging 35 (2014), 2746–2760, 10.1016/j.neurobiolaging.2014.06.004 (S0197–4580(14)00405–9 [pii]).
3. [3] Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., Finch, C.E., Frautschy, S., Griffin, W.S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I.R., McGeer, P.L., O'Banion, M.K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., van Muiswinkel, F.L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., Wyss-Coray, T., Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000), 383–421 (S019745800000124X [pii]).
4. [4] Cai, Z., Zhao, B., Ratka, A., Oxidative stress and beta-amyloid protein in Alzheimer's disease. Neruomol. Med. 13 (2011), 223–250, 10.1007/s12017–011–8155-9.
5. [5] Reed-Geaghan, E.G., Reed, Q.W., Cramer, P.E., Landreth, G.E., Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the Brain's inflammatory milieu. J. Neurosci. 30 (2010), 15369–15373, 10.1523/JNEUROSCI.2637-10.2010 (30/46/15369 [pii]).
6. [6] DiCarlo, G., Wilcock, D., Henderson, D., Gordon, M., Morgan, D., Intrahippocampal LPS injections reduce Abeta load in APP + PS1 transgenic mice. Neurobiol. Aging 22 (2001), 1007–1012 (S0197458001002925 [pii]).
7. [7] Graeber, M.B., Changing face of microglia. Science 330 (2010), 783–788, 10.1126/science.1190929 (330/6005/783 [pii]).
8. [8] Mizuno, T., The biphasic role of microglia in Alzheimer's disease. Int. J. Alzheimers Dis., 2012, 2012, 737846, 10.1155/2012/737846.
9. [9] Baron, R., Babcock, A.A., Nemirovsky, A., Finsen, B., Monsonego, A., Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell, 2014, 10.1111/acel.12210.
10. [10] Graeber, M.B., Streit, W.J., Microglia: biology and pathology. Acta Neuropathol. 119 (2010), 89–105, 10.1007/s00401–009–0622-0.
11. [11] Wirz, K.T., Bossers, K., Stargardt, A., Kamphuis, W., Swaab, D.F., Hol, E.M., Verhaagen, J., Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model. Neurobiol. Aging 34 (2013), 1328–1342, 10.1016/j.neurobiolaging.2012.11.008 (S0197–4580(12)00585–4 [pii]).
12. [12] Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., Feron, F., Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol. Neurodegener., 9, 2014, 33, 10.1186/1750–1326–9-33 (#N/A [pii]).
13. [13] Manczak, M., Mao, P., Nakamura, K., Bebbington, C., Park, B., Reddy, P.H., Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1–42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Hum. Mol. Genet. 18 (2009), 3876–3893, 10.1093/hmg/ddp331 (ddp331 [pii]).
14. [14] Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C.A., Tan, J., Duman, R.S., Flavell, R.A., Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14 (2008), 681–687, 10.1038/nm1781 (nm1781 [pii]).
15. [15] Vom Berg, J., Prokop, S., Miller, K.R., Obst, J., Kalin, R.E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C.G., Peters, O., Winter, Y., Becher, B., Heppner, F.L., Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 18 (2012), 1812–1819, 10.1038/nm.2965 (nm.2965 [pii]).
16. [16] Kan, M.J., Lee, J.E., Wilson, J.G., Everhart, A.L., Brown, C.M., Hoofnagle, A.N., Jansen, M., Vitek, M.P., Gunn, M.D., Colton, C.A., Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. J. Neurosci. 35 (2015), 5969–5982, 10.1523/JNEUROSCI.4668–14.2015 (35/15/5969 [pii]).
17. [17] Akiyama, H., McGeer, P.L., Brain microglia constitutively express beta-2 integrins. J. Neuroimmunol. 30 (1990), 81–93 (0165–5728(90)90055-R [pii]).
18. [18] Lindquist, R.L., Shakhar, G., Dudziak, D., Wardemann, H., Eisenreich, T., Dustin, M.L., Nussenzweig, M.C., Visualizing dendritic cell networks in vivo. Nat. Immunol. 5 (2004), 1243–1250, 10.1038/ni1139 (ni1139 [pii]).
19. [19] Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000), 767–811, 10.1146/annurev.immunol.18.1.767 (18/1/767 [pii]).
20. [20] Dresch, C., Edelmann, S.L., Marconi, P., Brocker, T., Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J. Immunol. 181 (2008), 4495–4506 (181/7/4495 [pii]).
21. [21] Immig, K., Gericke, M., Menzel, F., Merz, F., Krueger, M., Schiefenhovel, F., Losche, A., Jager, K., Hanisch, U.K., Biber, K., Bechmann, I., CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia 63 (2014), 611–625, 10.1002/glia.22771.
22. [22] Prodinger, C., Bunse, J., Kruger, M., Schiefenhovel, F., Brandt, C., Laman, J.D., Greter, M., Immig, K., Heppner, F., Becher, B., Bechmann, I., CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 121 (2011), 445–458, 10.1007/s00401–010-0774-y.
23. [23] Bulloch, K., Miller, M.M., Gal-Toth, J., Milner, T.A., Gottfried-Blackmore, A., Waters, E.M., Kaunzner, U.W., Liu, K., Lindquist, R., Nussenzweig, M.C., Steinman, R.M., McEwen, B.S., CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508 (2008), 687–710, 10.1002/cne.21668.
24. [24] Wlodarczyk, A., Lobner, M., Cedile, O., Owens, T., Comparison of microglia and infiltrating CD11c(+) cells as antigen presenting cells for T cell proliferation and cytokine response. J. Neuroinflammation 11:57 (2014), 1742–2094, 10.1186/1742–2094–11-57 (11-57 [pii]).
25. [25] Fischer, H.G., Reichmann, G., Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166 (2001), 2717–2726.
26. [26] Gomez-Nicola, D., Fransen, N.L., Suzzi, S., Perry, V.H., Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33 (2013), 2481–2493, 10.1523/JNEUROSCI.4440–12.2013 (33/6/2481 [pii]).
27. [27] Mausberg, A.K., Jander, S., Reichmann, G., Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain. Glia 57 (2009), 1341–1350, 10.1002/glia.20853.
28. [28] Felger, J.C., Abe, T., Kaunzner, U.W., Gottfried-Blackmore, A., Gal-Toth, J., McEwen, B.S., Iadecola, C., Bulloch, K., Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 24 (2010), 724–737, 10.1016/j.bbi.2009.11.002 (S0889–1591(09)00513–3 [pii]).
29. [29] Gottfried-Blackmore, A., Kaunzner, U.W., Idoyaga, J., Felger, J.C., McEwen, B.S., Bulloch, K., Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20918–20923, 10.1073/pnas.0911509106 (0911509106 [pii]).
30. [30] Jankowsky, J.L., Slunt, H.H., Gonzales, V., Jenkins, N.A., Copeland, N.G., Borchelt, D.R., APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol. Aging 25 (2004), 885–892.
31. [31] Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., Hol, E.M., Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia 60 (2012), 615–629, 10.1002/glia.22295.
32. [32] Kamphuis, W., Mamber, C., Moeton, M., Kooijman, L., Sluijs, J.A., Jansen, A.H., Verveer, M., de Groot, L.R., Smith, V.D., Rangarajan, S., Rodriguez, J.J., Orre, M., Hol, E.M., GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One, 7, 2012, e42823, 10.1371/journal.pone.0042823 (PONE-D-12-13276 [pii]).
33. [33] Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., LaFerla, F.M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003), 409–421.
34. [34] Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J.A., Kooi, E.J., Moeton, M., Freriks, M., Mizee, M.R., Hol, E.M., Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol. Aging 35 (2014), 492–510, 10.1016/j.neurobiolaging.2013.09.035 (S0197–4580(13)00437–5 [pii]).
35. [35] Orre, M., Kamphuis, W., Osborn, L.M., Melief, J., Kooijman, L., Huitinga, I., Klooster, J., Bossers, K., Hol, E.M., Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol. Aging 35 (2014), 1–14, 10.1016/j.neurobiolaging.2013.07.008 (S0197–4580(13)00313–8 [pii]).
36. [36] Bossers, K., Ylstra, B., Brakenhoff, R.H., Smeets, S.J., Verhaagen, J., van de Wiel, M.A., Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility. BMC Genomics 11 (2010), 112–1471, 10.1186/1471–2164–11-112 (2164–11-112 [pii]).
37. [37] Bolstad, B.M., Irizarry, R.A., Astrand, M., Speed, T.P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003), 185–193.
38. [38] Kamphuis, W., Kooijman, L., Orre, M., Stassen, O., Pekny, M., Hol, E.M., GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease. Glia 63 (2015), 1036–1056, 10.1002/glia.22800.
39. [39] Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A.M., Cialic, R., Wu, P.M., Doykan, C.E., Lin, J., Cotleur, A.C., Kidd, G., Zorlu, M.M., Sun, N., Hu, W., Liu, L., Lee, J.C., Taylor, S.E., Uehlein, L., Dixon, D., Gu, J., Floruta, C.M., Zhu, M., Charo, I.F., Weiner, H.L., Ransohoff, R.M., Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211 (2014), 1533–1549, 10.1084/jem.20132477 (jem.20132477 [pii]).
40. [40] Saederup, N., Cardona, A.E., Croft, K., Mizutani, M., Cotleur, A.C., Tsou, C.L., Ransohoff, R.M., Charo, I.F., Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One, 5, 2010, e13693, 10.1371/journal.pone.0013693.
41. [41] Mildner, A., Mack, M., Schmidt, H., Bruck, W., Djukic, M., Zabel, M.D., Hille, A., Priller, J., Prinz, M., CCR2 + Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132 (2009), 2487–2500, 10.1093/brain/awp144 (awp144 [pii]).
42. [42] Butovsky, O., Jedrychowski, M.P., Moore, C.S., Cialic, R., Lanser, A.J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P.M., Doykan, C.E., Fanek, Z., Liu, L., Chen, Z., Rothstein, J.D., Ransohoff, R.M., Gygi, S.P., Antel, J.P., Weiner, H.L., Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 17 (2014), 131–143, 10.1038/nn.3599 (nn.3599 [pii]).
43. [43] Mizutani, M., Pino, P.A., Saederup, N., Charo, I.F., Ransohoff, R.M., Cardona, A.E., The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188 (2012), 29–36, 10.4049/jimmunol.1100421 (jimmunol.1100421 [pii]).
44. [44] Hammer, G.E., Ma, A., Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31 (2013), 743–791, 10.1146/annurev-immunol-020711-074929.
45. [45] Taylor, P.R., Brown, G.D., Reid, D.M., Willment, J.A., Martinez-Pomares, L., Gordon, S., Wong, S.Y., The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169 (2002), 3876–3882.
46. [46] Wolburg, H., Paulus, W., Choroid plexus: biology and pathology. Acta Neuropathol. 119 (2010), 75–88, 10.1007/s00401–009–0627-8.
47. [47] Dustin, M.L., Signaling at neuro/immune synapses. J. Clin. Invest. 122 (2012), 1149–1155, 10.1172/JCI58705 (58705 [pii]).
48. [48] Holtman, I.R., Raj, D.D., Miller, J.A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P.D., Moller, T., Orre, M., Kamphuis, W., Hol, E.M., Boddeke, E.W., Eggen, B.J., Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol. Commun., 3, 2015, 31, 10.1186/s40478–015–0203-5 (10.1186/s40478–015–0203-5 [pii]).
49. [49] Hickman, S.E., Kingery, N.D., Ohsumi, T.K., Borowsky, M.L., Wang, L.C., Means, T.K., El, K.J., The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16 (2013), 1896–1905, 10.1038/nn.3554 (nn.3554 [pii]).
50. [50] Grabert, K., Michoel, T., Karavolos, M.H., Clohisey, S., Baillie, J.K., Stevens, M.P., Freeman, T.C., Summers, K.M., McColl, B.W., Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19 (2016), 504–516, 10.1038/nn.4222 (nn.4222 [pii]).
51. [51] Wlodarczyk, A., Cedile, O., Jensen, K.N., Jasson, A., Mony, J.T., Khorooshi, R., Owens, T., Pathologic and protective roles for microglial subsets and bone marrow- and blood-derived myeloid cells in central nervous system inflammation. Front. Immunol., 6, 2015, 463, 10.3389/fimmu.2015.00463.
52. [52] Castro, F.V., Tutt, A.L., White, A.L., Teeling, J.L., James, S., French, R.R., Glennie, M.J., CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur. J. Immunol. 38 (2008), 2263–2273, 10.1002/eji.200838302.
53. [53] Uotila, L.M., Aatonen, M., Gahmberg, C.G., Integrin CD11c/CD18 alpha-chain phosphorylation is functionally important. J. Biol. Chem. 288 (2013), 33494–33499, 10.1074/jbc.C113.497446 (C113.497446 [pii]).
54. [54] Colton, C.A., Immune heterogeneity in neuroinflammation: dendritic cells in the brain. J. NeuroImmune Pharmacol. 8 (2013), 145–162, 10.1007/s11481–012–9414-8.
55. [55] D'Agostino, P.M., Gottfried-Blackmore, A., Anandasabapathy, N., Bulloch, K., Brain dendritic cells: biology and pathology. Acta Neuropathol. 124 (2012), 599–614, 10.1007/s00401–012–1018-0.
56. [56] Li, X.W., Yang, F., Wang, Y.G., Wang, J.C., Ma, L., Jiang, W., Brain recruitment of dendritic cells following Li-pilocarpine induced status epilepticus in adult rats. Brain Res. Bull. 91 (2012), 8–13, 10.1016/j.brainresbull.2012.11.007 (S0361–9230(12)00245–6 [pii]).
57. [57] Hollenbach, R., Sagar, D., Khan, Z.K., Callen, S., Yao, H., Shirazi, J., Buch, S., Jain, P., Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaques. J. Neurovirol. 20 (2013), 175–183, 10.1007/s13365–013-0182-x.
58. [58] Hatterer, E., Touret, M., Belin, M.F., Honnorat, J., Nataf, S., Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions. PLoS One, 3, 2008, e3321, 10.1371/journal.pone.0003321.
59. [59] Steel, C.D., Hahto, S.M., Ciavarra, R.P., Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system. Virology 387 (2009), 117–126, 10.1016/j.virol.2009.01.032 (S0042–6822(09)00072–5 [pii]).
60. [60] El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C., Luster, A.D., Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13 (2007), 432–438, 10.1038/nm1555 (nm1555 [pii]).
61. [61] Naert, G., Rivest, S., CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 31 (2011), 6208–6220, 10.1523/JNEUROSCI.0299–11.2011 (31/16/6208 [pii]).
62. [62] Jana, M., Palencia, C.A., Pahan, K., Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol. 181 (2008), 7254–7262 (181/10/7254 [pii]).
63. [63] Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., Schwartz, M., Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 11784–11789, 10.1073/pnas.0604681103 (0604681103 [pii]).
64. [64] Nichol, K.E., Poon, W.W., Parachikova, A.I., Cribbs, D.H., Glabe, C.G., Cotman, C.W., Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J. Neuroinflammation, 5, 2008, 10.1186/1742–2094–5-13 (13. 1742–2094–5-13 [pii]).
65. [65] Shi, J.Q., Shen, W., Chen, J., Wang, B.R., Zhong, L.L., Zhu, Y.W., Zhu, H.Q., Zhang, Q.Q., Zhang, Y.D., Xu, J., Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res. 1368 (2010), 239–247, 10.1016/j.brainres.2010.10.053 (S0006–8993(10)02322-X [pii]).
66. [66] Zhang, C., Liu, Y., Gilthorpe, J., van der Maarel, J.R., MRP14 (S100 A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One, 7, 2012, e32953, 10.1371/journal.pone.0032953 (PONE-D-11-23609 [pii]).
67. [67] Riva, M., Kallberg, E., Bjork, P., Hancz, D., Vogl, T., Roth, J., Ivars, F., Leanderson, T., Induction of nuclear factor-kappaB responses by the S100 A9 protein is toll-like receptor-4-dependent. Immunology 137 (2012), 172–182, 10.1111/j.1365–2567.2012.03619.x.
68. [68] Chang, K.A., Kim, H.J., Suh, Y.H., The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout. Neurodegener. Dis. 10 (2012), 27–29, 10.1159/000333781 (000333781 [pii]).
69. [69] Kummer, M.P., Vogl, T., Axt, D., Griep, A., Vieira-Saecker, A., Jessen, F., Gelpi, E., Roth, J., Heneka, M.T., Mrp14 deficiency ameliorates amyloid beta burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J. Neurosci. 32 (2012), 17824–17829, 10.1523/JNEUROSCI.1504–12.2012 (32/49/17824 [pii]).
70. [70] Hickman, S.E., El, K.J., TREM2 and the neuroimmunology of Alzheimer's disease. Biochem. Pharmacol. 88 (2014), 495–498, 10.1016/j.bcp.2013.11.021 (S0006–2952(13)00755–7 [pii]).
71. [71] Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B., Lemke, G., TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 (2007), 1124–1136, 10.1016/j.cell.2007.10.034 (S0092–8674(07)01352–9 [pii]).
72. [72] Griffin, E.W., Skelly, D.T., Murray, C.L., Cunningham, C., Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J. Neurosci. 33 (2013), 15248–15258, 10.1523/JNEUROSCI.6361–11.2013 (33/38/15248 [pii]).
73. [73] Trinath, J., Holla, S., Mahadik, K., Prakhar, P., Singh, V., Balaji, K.N., The WNT signaling pathway contributes to dectin-1-dependent inhibition of toll-like receptor-induced inflammatory signature. Mol. Cell. Biol. 34 (2014), 4301–4314, 10.1128/MCB.00641–14 (MCB.00641–14 [pii]).
74. [74] Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M., Lamb, B.T., CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177 (2010), 2549–2562, 10.2353/ajpath.2010.100265 (S0002–9440(10)60305–7 [pii]).
75. [75] Chung, J.S., Sato, K., Dougherty, I.I., Cruz, P.D. Jr., Ariizumi, K., DC-HIL is a negative regulator of T-lymphocyte activation. Blood 109 (2007), 4320–4327, 10.1182/blood-2006-11-053769 (blood-2006-11-053769 [pii]).
76. [76] Vlad, G., Chang, C.C., Colovai, A.I., Vasilescu, E.R., Cortesini, R., Suciu-Foca, N., Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int. Rev. Immunol. 29 (2010), 119–132, 10.3109/08830180903281185.
77. [77] Chan, J.L., Reeves, T.M., Phillips, L.L., Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury. Exp. Neurol. 261 (2014), 757–771, 10.1016/j.expneurol.2014.08.015 (S0014–4886(14)00267–2 [pii]).
78. [78] Pascual-Lucas, M., Viana da Silva, S., Di Scala, M., Garcia-Barroso, C., Gonzalez-Aseguinolaza, G., Mulle, C., Alberini, C.M., Cuadrado-Tejedor, M., Garcia-Osta, A., Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol. Med. 6 (2014), 1246–1262, 10.15252/emmm.201404228 (emmm.201404228 [pii]).
79. [79] Gasparini, L., Xu, H., Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci. 26 (2003), 404–406, 10.1016/S0166–2236(03)00163–2 (S0166–2236(03)00163–2 [pii]).
80. [80] Werner, H., Leroith, D., Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects. Eur. Neuropsychopharmacol. 24 (2014), 1947–1953, 10.1016/j.euroneuro.2014.01.020 (S0924-977 ×(14)00041–8 [pii]).
81. [81] Griffin, W.S., Neuroinflammatory cytokine signaling and Alzheimer's disease. N. Engl. J. Med. 368 (2013), 770–771, 10.1056/NEJMcibr1214546.
82. [82] Richard, K.L., Filali, M., Prefontaine, P., Rivest, S., Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1–42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 28 (2008), 5784–5793, 10.1523/JNEUROSCI.1146–08.2008 (28/22/5784 [pii]).
83. [83] Chakrabarty, P., Jansen-West, K., Beccard, A., Ceballos-Diaz, C., Levites, Y., Verbeeck, C., Zubair, A.C., Dickson, D., Golde, T.E., Das, P., Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J., 24, 2010, 10.1096/fj.09–141754 (548–559. fj.09–141754 [pii]).
84. [84] Zhu, Y., Hou, H., Rezai-Zadeh, K., Giunta, B., Ruscin, A., Gemma, C., Jin, J., Dragicevic, N., Bradshaw, P., Rasool, S., Glabe, C.G., Ehrhart, J., Bickford, P., Mori, T., Obregon, D., Town, T., Tan, J., CD45 deficiency drives amyloid-β} peptide oligomers and neuronal loss in Alzheimer's disease mice. J. Neurosci. 31 (2011), 1355–1365, 10.1523/JNEUROSCI.3268–10.2011 (31/4/1355 [pii]).
85. [85] Wyss-Coray, T., Yan, F., Lin, A.H., Lambris, J.D., Alexander, J.J., Quigg, R.J., Masliah, E., Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 10837–10842.
86. [86] Cheng, C.M., Reinhardt, R.R., Lee, W.H., Joncas, G., Patel, S.C., Bondy, C.A., Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 10236–10241, 10.1073/pnas.170008497 (170008497 [pii]).
87. [87] Pedros, I., Petrov, D., Allgaier, M., Sureda, F., Barroso, E., Beas-Zarate, C., Auladell, C., Pallas, M., Vazquez-Carrera, M., Casadesus, G., Folch, J., Camins, A., Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim. Biophys. Acta 1842 (2014), 1556–1566, 10.1016/j.bbadis.2014.05.025 (S0925–4439(14)00153–7 [pii]).
88. [88] Wang, F., Liu, H., Shen, X., Ao, H., Moore, N., Gao, L., Chen, L., Hu, H., Ma, H., Yang, Z., Zhai, C., Qin, J., Zhou, G., Peng, Y., Feng, X., Li, R., Liang, C., The combined treatment of amyloid-beta-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice. Neurobiol. Aging 36 (2014), 111–122, 10.1016/j.neurobiolaging.2014.06.029 (S0197–4580(14)00468–0 [pii]).
89. [89] Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E.D., Sun, B., Chen, J., Wang, X., Yu, G., Esposito, L., Mucke, L., Gan, L., Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51 (2006), 703–714, 10.1016/j.neuron.2006.07.027 (S0896–6273(06)00597–6 [pii]).
90. [90] Wang, C., Sun, B., Zhou, Y., Grubb, A., Gan, L., Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein. J. Biol. Chem. 287 (2012), 39834–39841, 10.1074/jbc.M112.371641 (M112.371641 [pii]).
91. [91] Hauser, P.S., Ryan, R.O., Impact of apolipoprotein E on Alzheimer's disease. Curr. Alzheimer Res. 10 (2013), 809–817 (CAR-EPUB-55023 [pii).
92. [92] Wildsmith, K.R., Holley, M., Savage, J.C., Skerrett, R., Landreth, G.E., Evidence for impaired amyloid beta clearance in Alzheimer's disease. Alzheimers Res. Ther., 5, 2013, 33, 10.1186/alzrt187 (alzrt187 [pii]).
93. [93] Jiang, Q., Lee, C.Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T.M., Collins, J.L., Richardson, J.C., Smith, J.D., Comery, T.A., Riddell, D., Holtzman, D.M., Tontonoz, P., Landreth, G.E., ApoE promotes the proteolytic degradation of Abeta. Neuron 58 (2008), 681–693, 10.1016/j.neuron.2008.04.010 (S0896–6273(08)00328–0 [pii]).
94. [94] Lee, C.Y., Landreth, G.E., The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117 (2010), 949–960, 10.1007/s00702–010–0433-4.
95. [95] Chiasserini, D., Parnetti, L., Andreasson, U., Zetterberg, H., Giannandrea, D., Calabresi, P., Blennow, K., CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. J. Alzheimers Dis. 22 (2010), 1281–1288, 10.3233/JAD-2010-101293 (66400686ML4P3250 [pii]).